Inder Kaul

Inder is the Chief Medical Officer of Draig Therapeutics. He is a physician and experienced global drug development leader with a track record of success in regulatory project achievement, portfolio governance, translational science and commercialization support. His expertise spans multiple therapeutic areas with a focus in neuroscience. Inder has successfully filed and supported multiple INDs, NDAs, sNDAs, PIPs, PSPs, PMAs and 510(k)s. He is a skilled leader of global cross-functional teams that determine product strategy with integration of clinical development, regulatory and commercial recommendations. Inder has extensive regulatory experience with FDA, EMA, DCGI, MOHs (APAC, LA and non-EU countries) and HC. He has held a variety of leadership roles at small, mid and large biotech/pharma companies, including Senior Vice President Clinical Development at Bristol Myers Squibb and Karuna Therapeutics.

Inder holds a MD degree, and a MPH from Harvard University.